Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

BioPharma Credit Investments (BPCR) Ord

Sell:$0.97 Buy:$0.98 0 Change: $0.004 (0.41%)
Market closed Prices as at close on 20 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.97
Buy:$0.98
Change: $0.004 (0.41%)
Market closed Prices as at close on 20 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.97
Buy:$0.98
Change: $0.004 (0.41%)
Market closed Prices as at close on 20 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
$0.97
Trade high:
$0.98
Year high:
$1.03
Estimated NAV:
99.17
Previous close:
$0.98
Trade low:
$0.97
Year low:
$0.95
Premium/Discount:
-1.99%
Previous:
$0.00 (0.21%)
Previous:
$0.00
Volume:
3,393,304
Dividend yield:
7.17%
Currency:
USD
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
BIOPHARMA CRED. performance chart

Premium/Discount

BIOPHARMA CRED. performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 0.21% 1 year 1Y 4.02%
1 month 1M 0.81% 2 years 2Y 3.27%
3 months 3M 0.72% 3 years 3Y 7.61%
6 months 6M 1.46% 5 years 5Y n/a

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: AIC Investment Trust Debt Sector USD
Annual management charge: 1% of Net Assets
Performance fee: Yes
Ongoing charge: 1.48%
Dividend yield: 7.17%
Dividend frequency: Quarterly
Total assets: £1,363m
Gross gearing: 100%
Market capitalisation:Market cap.: £1,335m
Shares in issue: 1.37 bn
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB00BDGKMY29

Recent dividends paid or declared by BioPharma Credit Investments:

Type Ex-div date Payment date Amount
2nd interim 19/08/2021 17/09/2021 1.75¢
1st interim 03/06/2021 30/06/2021 1.75¢
Special 18/03/2021 16/04/2021 0.2901¢
4th interim 18/03/2021 16/04/2021 1.75¢
Special 19/11/2020 18/12/2020 0.01¢

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual BioPharma Credit Investments dividends:

Financial
year end
Dividend
yield
Dividend
cover
Total dividend
paid
31/12/2020 7.00% 0.83 $0.07
31/12/2019 6.90% 1.18 $0.07
31/12/2018 6.50% 1.02 $0.07
31/12/2017 2.90% 1.30 $0.04

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Ready to invest?

To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.

Compare accounts

Ready to invest?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents



Objective

The company will seek to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The company will seek to achieve its investment objective predominantly through direct or indirect exposure to Debt Assets. The Company may also invest in equity issued by a LifeSci Company, acquired directly from the LifeSci Company; or in the secondary market.

NET ASSET VALUE (NAV)

Estimated NAV: 99.17
Latest actual NAV: 73.17
Latest actual NAV date: 31 July 2021
Premium/Discount: -1.99%
12m average Premium/Discount: -1.47%
NAV frequency: Monthly

Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

Security Weight
Sarepta Therapeutics Inc 25.21%
Collector AB 9.66%
Epizyme Inc 7.92%
Sebela Senior Secured Loan 6.65%
Global Blood Therapeutics Inc 5.94%
Biodelivery Sciences International Loan 5.76%
Opti Nose US Note 5.15%
Akebia Therapeutics Inc 3.60%
BioDelivery Sciences International Inc 0.82%
Opti Nose Us Warrants 0.02%
Sector Weight
Healthcare 43.50%
Financial Services 9.66%
Country Weight
United States 43.50%
Sweden 9.66%

Key Dates

Launch date: 22 March 2017
Financial year end: December
Next AGM: June 2022
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.